Cargando…
Cryptotanshinone inhibits esophageal squamous-cell carcinoma in vitro and in vivo through the suppression of STAT3 activation
PURPOSE: Esophageal squamous-cell carcinoma (ESCC) is the most common subtype of esophageal cancer, with a poor clinical outcome. Cryptotanshinone (CTS) is the main bioactive compound from the root of Salvia miltiorrhiza Bunge. Our study aimed to investigate the anti-cancer effects and molecular mec...
Autores principales: | Ji, Yubin, Liu, Yichen, Xue, Nina, Du, Tingting, Wang, Liyuan, Huang, Rui, Li, Ling, Yan, Chunhong, Chen, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357882/ https://www.ncbi.nlm.nih.gov/pubmed/30774375 http://dx.doi.org/10.2147/OTT.S187777 |
Ejemplares similares
-
Cryptotanshinone Attenuated Pathological Cardiac Remodeling In Vivo and In Vitro Experiments
por: Li, Wen-jing, et al.
Publicado: (2023) -
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
por: Lu, Liang, et al.
Publicado: (2017) -
Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma
por: Chen, Zhiguo, et al.
Publicado: (2017) -
Development of cryptotanshinone-loaded pellets for angina chronotherapy: In vitro/in vivo prediction and evaluation()
por: Li, Zhenghua, et al.
Publicado: (2018) -
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo
por: Shen, Li, et al.
Publicado: (2017)